Advances in Complementary & Alternative medicine>Adv Complement Alt Med, 2018>146-154
Objectives: The present study investigated antihyperglycemic, and antioxidant potentials of Eugenia jambolana seed in streptozotocin (STZ)induced diabetic rats. Methods: Male Wistar rats were made diabetic by a single dose of Streptozotocin (45mg/kg body weight .i.p). The animals were administered of ethanolic extract of Eugenia jambolana (E. jambolana) seed at the dose of (250mg/kg body weight) orally. The therapeutic functions of the E. jambolana was assessed by monitoring, Blood glucose levels and body weight of rats were measured at weekly intervals and glycosylated hemoglobin, lipid profile and biomarkers of oxidative stress, liver and kidney function markers and degree of DNA damage were also measured at the end of the study. Result: Daily administration of E. jambolana seed extract for 28 days resulted in significant reductions of blood glucose and glycosylated hemoglobin levels. There was also a significant increase in HDL-Cholesterol levels with concomitant decreases in total cholesterol, triglycerides, LDL-Cholesterol, VLDL. Also, a significant improvement in enzymatic and non-enzymatic biochemical markers of oxidative stress. The kidney and liver functions were also reverted back to near normalcy by E. jambolana ethanolic seed extract. Conclusion: The present results showed the anti-hyperglycemic, and anti-oxidative potential of of ethanolic extract of E. jambolana in STZ induced diabetic rats. It was concluded that the ethanolic extract of E. jambolana is potent in regulating not only hyperglycemia but also hyperlipidemia and oxidative stress in STZ induced diabetic rats.
Kesavadev J, Saboo B, Sadikot S, Das AK, Joshi S, et al. (2017) Unproven therapies for diabetes and their implications. Adv Ther 34(1): 60-77.
American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus. Diabetes Care 36(Suppl 1): S67-S74.
Erekat, N. S., Al-Jarrah, M. D., & Al Khatib, A. J. (2014). Treadmill exercise training improves vascular endothelial growth factor expression in the cardiac muscle of type I diabetic rats. Cardiology research, 5(1), 23.
Financed by the National Centre for Research and Development under grant No. SP/I/1/77065/10 by the strategic scientific research and experimental development program:
SYNAT - “Interdisciplinary System for Interactive Scientific and Scientific-Technical Information”.